A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients-Reference-Cited by-同舟云学术

A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients

Published:2007-04 Issue:5 Volume:67 Page:1323-1331
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Willey Christopher D.,Murphy Barbara A.,Netterville James L.,Burkey Brian B.,Shyr Yu,Shakhtour Bashar,Kish Bonnie,Raben David,Chen Changhu,Song John I.,Kane Madeleine A.,Cmelak Anthony J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference83 articles.

1. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;N Engl J Med,2004

2. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck;Cooper;N Engl J Med,2004

3. Taxol stabilizes microtubules in mouse fibroblast cells;Schiff;Proc Natl Acad Sci U S A,1980

4. Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis;Tomiak;J Clin Oncol,1994

5. Phase I clinical trial of Taxotere administered as either a 2-hour or 6-hour intravenous infusion;Burris;J Clin Oncol,1993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma;Head & Neck;2014-01-29

2. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer;Cochrane Database of Systematic Reviews;2009-07-08

3. Evolution of clinical trials in head and neck cancer;Critical Reviews in Oncology/Hematology;2009-07

4. Phase I/II Study of Biweekly Paclitaxel and Radiation in Androgen-Ablated Locally Advanced Prostate Cancer;Journal of Clinical Oncology;2008-06-20